You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has ninety-three approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms
US Patents:0

Drugs and US Patents for Glenmark Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms MUPIROCIN mupirocin OINTMENT;TOPICAL 090480-001 Jun 8, 2011 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Ltd PIMECROLIMUS pimecrolimus CREAM;TOPICAL 211769-001 Aug 29, 2019 AB RX No No   Start Trial   Start Trial
Glenmark Pharms AZELAIC ACID azelaic acid GEL;TOPICAL 204637-001 Nov 19, 2018 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.